An improved screening model to identify inhibitors targeting zinc-enhanced amyloid aggregation

Pei Teh Chang, Fan Lu Kung, Rahul Subhash Talekar, Chien Shu Chen, Shin Yu Lai, Hsueh Yun Lee, Ji Wang Chern

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Zinc, which is abundant in senile plaques consisting mainly of fibrillar β-amyloid (Aβ), plays a critical role in the pathogenesis of Alzheimer's disease. Treatment with zinc chelators such as clioquinol has been used to prevent Aβ aggregation in Alzheimer's patients; however, clioquinol produces severe side effects. A simple, easy, inexpensive, and versatile screen to identify zinc chelators for inhibition of Aβ aggregation is currently unavailable. We thus developed a high-throughput screen that identi-fies zinc chelators with anti-Aβ aggregation activity. The recombinant Aβ peptides, aggregated on solid-phase microplates, formed Aβ-immunopositive β-sheet-containing structures in the presence of zinc. Formation of these Aβ fibrils was specifically blocked by metal ion chelators. This screening model improves identification of zinc-enhanced Aβ fibrils and anti-Aβ aggregation mediated by zinc chelating. The convenient system could qualitatively and quantitatively assay a large sample pool for Aβ aggregation inhibition and dissolution of Aβ aggregates. This screen is practical, reliable, and versatile for comprehensive detection of amyloid fibrillation and identification of inhibitors of Aβ aggregation.

Original languageEnglish
Pages (from-to)6944-6951
Number of pages8
JournalAnalytical Chemistry
Volume81
Issue number16
DOIs
Publication statusPublished - Aug 15 2009
Externally publishedYes

Fingerprint

Amyloid
Zinc
Screening
Agglomeration
Chelating Agents
Clioquinol
Chelation
Metal ions
Assays
Identification (control systems)
Dissolution
Throughput
Peptides

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Chang, P. T., Kung, F. L., Talekar, R. S., Chen, C. S., Lai, S. Y., Lee, H. Y., & Chern, J. W. (2009). An improved screening model to identify inhibitors targeting zinc-enhanced amyloid aggregation. Analytical Chemistry, 81(16), 6944-6951. https://doi.org/10.1021/ac901011e

An improved screening model to identify inhibitors targeting zinc-enhanced amyloid aggregation. / Chang, Pei Teh; Kung, Fan Lu; Talekar, Rahul Subhash; Chen, Chien Shu; Lai, Shin Yu; Lee, Hsueh Yun; Chern, Ji Wang.

In: Analytical Chemistry, Vol. 81, No. 16, 15.08.2009, p. 6944-6951.

Research output: Contribution to journalArticle

Chang, PT, Kung, FL, Talekar, RS, Chen, CS, Lai, SY, Lee, HY & Chern, JW 2009, 'An improved screening model to identify inhibitors targeting zinc-enhanced amyloid aggregation', Analytical Chemistry, vol. 81, no. 16, pp. 6944-6951. https://doi.org/10.1021/ac901011e
Chang, Pei Teh ; Kung, Fan Lu ; Talekar, Rahul Subhash ; Chen, Chien Shu ; Lai, Shin Yu ; Lee, Hsueh Yun ; Chern, Ji Wang. / An improved screening model to identify inhibitors targeting zinc-enhanced amyloid aggregation. In: Analytical Chemistry. 2009 ; Vol. 81, No. 16. pp. 6944-6951.
@article{36583e33db7442c2946df3ed5c78a523,
title = "An improved screening model to identify inhibitors targeting zinc-enhanced amyloid aggregation",
abstract = "Zinc, which is abundant in senile plaques consisting mainly of fibrillar β-amyloid (Aβ), plays a critical role in the pathogenesis of Alzheimer's disease. Treatment with zinc chelators such as clioquinol has been used to prevent Aβ aggregation in Alzheimer's patients; however, clioquinol produces severe side effects. A simple, easy, inexpensive, and versatile screen to identify zinc chelators for inhibition of Aβ aggregation is currently unavailable. We thus developed a high-throughput screen that identi-fies zinc chelators with anti-Aβ aggregation activity. The recombinant Aβ peptides, aggregated on solid-phase microplates, formed Aβ-immunopositive β-sheet-containing structures in the presence of zinc. Formation of these Aβ fibrils was specifically blocked by metal ion chelators. This screening model improves identification of zinc-enhanced Aβ fibrils and anti-Aβ aggregation mediated by zinc chelating. The convenient system could qualitatively and quantitatively assay a large sample pool for Aβ aggregation inhibition and dissolution of Aβ aggregates. This screen is practical, reliable, and versatile for comprehensive detection of amyloid fibrillation and identification of inhibitors of Aβ aggregation.",
author = "Chang, {Pei Teh} and Kung, {Fan Lu} and Talekar, {Rahul Subhash} and Chen, {Chien Shu} and Lai, {Shin Yu} and Lee, {Hsueh Yun} and Chern, {Ji Wang}",
year = "2009",
month = "8",
day = "15",
doi = "10.1021/ac901011e",
language = "English",
volume = "81",
pages = "6944--6951",
journal = "Analytical Chemistry",
issn = "0003-2700",
publisher = "American Chemical Society",
number = "16",

}

TY - JOUR

T1 - An improved screening model to identify inhibitors targeting zinc-enhanced amyloid aggregation

AU - Chang, Pei Teh

AU - Kung, Fan Lu

AU - Talekar, Rahul Subhash

AU - Chen, Chien Shu

AU - Lai, Shin Yu

AU - Lee, Hsueh Yun

AU - Chern, Ji Wang

PY - 2009/8/15

Y1 - 2009/8/15

N2 - Zinc, which is abundant in senile plaques consisting mainly of fibrillar β-amyloid (Aβ), plays a critical role in the pathogenesis of Alzheimer's disease. Treatment with zinc chelators such as clioquinol has been used to prevent Aβ aggregation in Alzheimer's patients; however, clioquinol produces severe side effects. A simple, easy, inexpensive, and versatile screen to identify zinc chelators for inhibition of Aβ aggregation is currently unavailable. We thus developed a high-throughput screen that identi-fies zinc chelators with anti-Aβ aggregation activity. The recombinant Aβ peptides, aggregated on solid-phase microplates, formed Aβ-immunopositive β-sheet-containing structures in the presence of zinc. Formation of these Aβ fibrils was specifically blocked by metal ion chelators. This screening model improves identification of zinc-enhanced Aβ fibrils and anti-Aβ aggregation mediated by zinc chelating. The convenient system could qualitatively and quantitatively assay a large sample pool for Aβ aggregation inhibition and dissolution of Aβ aggregates. This screen is practical, reliable, and versatile for comprehensive detection of amyloid fibrillation and identification of inhibitors of Aβ aggregation.

AB - Zinc, which is abundant in senile plaques consisting mainly of fibrillar β-amyloid (Aβ), plays a critical role in the pathogenesis of Alzheimer's disease. Treatment with zinc chelators such as clioquinol has been used to prevent Aβ aggregation in Alzheimer's patients; however, clioquinol produces severe side effects. A simple, easy, inexpensive, and versatile screen to identify zinc chelators for inhibition of Aβ aggregation is currently unavailable. We thus developed a high-throughput screen that identi-fies zinc chelators with anti-Aβ aggregation activity. The recombinant Aβ peptides, aggregated on solid-phase microplates, formed Aβ-immunopositive β-sheet-containing structures in the presence of zinc. Formation of these Aβ fibrils was specifically blocked by metal ion chelators. This screening model improves identification of zinc-enhanced Aβ fibrils and anti-Aβ aggregation mediated by zinc chelating. The convenient system could qualitatively and quantitatively assay a large sample pool for Aβ aggregation inhibition and dissolution of Aβ aggregates. This screen is practical, reliable, and versatile for comprehensive detection of amyloid fibrillation and identification of inhibitors of Aβ aggregation.

UR - http://www.scopus.com/inward/record.url?scp=68849121244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849121244&partnerID=8YFLogxK

U2 - 10.1021/ac901011e

DO - 10.1021/ac901011e

M3 - Article

C2 - 19621898

AN - SCOPUS:68849121244

VL - 81

SP - 6944

EP - 6951

JO - Analytical Chemistry

JF - Analytical Chemistry

SN - 0003-2700

IS - 16

ER -